Bill Summary
SB 1750 International Drug Reference Pricing (2024 Session)
International Drug Reference Pricing; Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc. Effective Date: 7/1/2024
01/05/24
SENATE
Filed
01/11/24
SENATE
Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
03/08/24
SENATE
Died in Health Policy
No amendments to this bill text filed.
465.0244
499.044
627.6044
641.3
![](https://cdn.lobbytools.com/public-lobbytools/images/icon_star.png)
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
![](https://cdn.lobbytools.com/public-lobbytools/images/icon_star.png)
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
![](https://cdn.lobbytools.com/public-lobbytools/images/icon_star.png)
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.